|
ACGT 10th Anniversary Celebration:
New Frontiers in Cancer Cell and Gene Therapy,
Honoring the Life of Edward Netter
Thursday, April 19, 2012,
at the Hyatt Regency in
Greenwich, Connecticut
GREENWICH, Conn.– The Alliance for Cancer Gene Therapy (ACGT)
is celebrating its tenth anniversary on Thursday, April
19, 2012, at 6:30 p.m., with a tribute dinner honoring
co-founder Edward Netter (1932-2011). The evening
appropriately titled New Frontiers will
be held at the Hyatt Regency in Greenwich, Connecticut.
Robert Bazell, chief science and health correspondent
for NBC News, will be the keynote speaker. Individual
Tickets: $375; other support levels available. For tickets
or additional information, please visit
http://www.ACGTFoundation.org or call
203-358-8000 or email
ghastings@acgtfoundation.org.
Edward Netter was the visionary, who together with his wife
Barbara sought New Frontiers to ease and erase the
ravages of cancer. The result of their years of dedication
is the breakthrough science, such as the recent and
promising study on leukemia that exceeded the‘wildest
expectations,’ and was made possible by the Alliance for
Cancer Gene Therapy.
Please celebrate Edward Netter’s life and his vision by
joining ACGT for this special tribute. ACGT anticipates that
this event will be fully subscribed, so please make plans
early. There are many options of support available. Barbara
Netter, president and co-founder of ACGT, and Sharon Walsted
Phillips, ACGT board member, are co-chairs of the event.
The Alliance for Cancer Gene Therapy (ACGT) is the nation’s
only non-profit dedicated exclusively to cell and gene
cancer therapy research. 100 percent of all contributions
to ACGT go directly to research and fund grants with leading
scientists in the U.S., representing such institutions as
Harvard Medical School, Johns Hopkins University School of
Medicine, Mayo Clinic, St. Jude’s Children’s Hospital, Duke
University, The Salk Institute, University of Pennsylvania,
Memorial Sloan-Kettering, Stanford University, Dana Farber
Cancer Center, University of California San Diego,
University of Pittsburgh, and the University of Chicago. A
rigorous grant review by Scientific Advisory Council ensures
the most promising projects are rewarded. To learn more
about the Alliance for Cancer Gene Therapy, visit
www.acgtfoundation.org or call 203-358-8000.
|